We are live on ! Find out more
EM

Excalibur Management Portfolio holdings

AUM $303M
1-Year Est. Return 26.92%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+26.92%
3 Year Est. Return
+81.69%
5 Year Est. Return
+107.45%
10 Year Est. Return
+270.69%
AUM
$118M
AUM Growth
+$6.11M
Cap. Flow
+$2.23M
Cap. Flow %
1.89%
Top 10 Hldgs %
51.23%
Holding
80
New
10
Increased
20
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
CSL icon
Carlisle Companies
CSL
+$1.39M
2
CPB icon
Campbell Soup
CPB
+$477K
3
QCOM icon
Qualcomm
QCOM
+$434K
4
WFC icon
Wells Fargo
WFC
+$370K
5
GIS icon
General Mills
GIS
+$343K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$416K
2
INTC icon
Intel
INTC
+$312K
3
KO icon
Coca-Cola
KO
+$295K
4
PG icon
Procter & Gamble
PG
+$289K
5
DD
Du Pont De Nemours E I
DD
+$236K

Sector Composition

Rank Sector Weight
1 Healthcare 21.22%
2 Industrials 15.51%
3 Financials 14.47%
4 Communication Services 13.68%
5 Technology 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOPN icon
76
Kopin
KOPN
$809M
$60K 0.05%
+14,500
New +$56.8K
AVEO
77
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$40K 0.03%
+1,100
New +$34K
SIGA icon
78
SIGA Technologies
SIGA
$218M
$38K 0.03%
+12,000
New +$38K
AGN
79
DELISTED
Allergan plc
AGN
-913
Closed -$222K
DD
80
DELISTED
Du Pont De Nemours E I
DD
-2,930
Closed -$236K

Similar funds

Excalibur Management's Q3 2017 Portfolio in Review

As of Q3 2017, Excalibur Management held 80 positions worth $118M, up 5.5% from $112M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Excalibur Management's Q3 2017 filing shows 10 new, 20 increased, 26 reduced and 2 closed positions. Its largest new stake was Campbell Soup: 9,409 shares worth $441K. The largest sale was Merck, an estimated $416K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Financials.

  • Excalibur Management's largest Q3 2017 buy was Campbell Soup: 9,409 shares worth $441K.
  • Excalibur Management added most to Carlisle Companies in Q3 2017, an estimated $1.39M increase.
  • Excalibur Management's biggest Q3 2017 reduction was Merck, cutting an estimated $416K.
  • Excalibur Management fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $236K.
  • Excalibur Management's ten largest holdings make up 51% of its $118M portfolio in Q3 2017.
  • Excalibur Management opened 10 new positions and closed 2 in Q3 2017.
  • Excalibur Management's portfolio value rose 5.5% quarter-over-quarter to $118M.

Based on Excalibur Management's 13F filing for Q3 2017, filed 25 Oct 2017.